It has been a horrible year for WiseTech Global Ltd (ASX: WTC) shareholders.

The logistics software stock is down another 1.39% to $34.76 on Wednesday, taking its 12-month decline to around 63%.

WiseTech shares are also down almost 50% in 2026 and miles below their 52-week high of $99.53.

But at $34.76, I think the sell-off has gone way too far.

Yes, WiseTech still has plenty to prove, but the business is growing, generating cash, and remains a global logistics leader.

If management delivers on its FY27 targets, I think WiseTech shares could have plenty of room to recover from here.

Here’s why.

The business is still growing

You wouldn’t know it from the share price, but WiseTech is still putting up some very strong numbers.

FY26 revenue jumped 79% to US$1.4 billion following the e2open acquisition, while underlying net profit increased 29% to US$313.5 million.

What really catches my attention is the cash flow.

Underlying free cash flow climbed 67% to US$489.6 million, giving WiseTech plenty of firepower to invest in growth, reduce debt, and keep improving the business.

The e2open deal is also starting to show some early benefits.

Management delivered around US$115 million of annualised cost savings during FY26, including US$64 million from e2open.

To me, that’s a pretty encouraging start.

If WiseTech can keep pulling costs out while growing the combined business, I think earnings and cash flow could move much higher over the next few years.

Margins could be heading higher

WiseTech is expecting FY27 revenue of US$1.48 billion to US$1.54 billion, which would represent growth of 6% to 10%.

But I think the earnings outlook is where things get much more interesting.

Underlying EBITDA is forecast to rise between 12% and 21% to US$725 million to US$780 million, with margins expected to improve to between 49% and 51%.

There’s also plenty happening underneath those numbers.

WiseTech currently has 12 large global freight forwarder rollouts underway, while more than 95% of customers have moved onto CargoWise Value Packs.

SME signings have also increased around 55% since the new pricing model was introduced.

That gives me plenty of confidence heading into FY27.

Brokers see huge upside

I am not the only one who is bullish on WiseTech at these levels.

According to TipRanks, there are 9 buy ratings and just 1 hold among 10 ranked analysts, with an average price target of $58.12.

That’s around 67% above the current share price.

Morgans has a $62.50 target, Bell Potter is at $65, while Morgan Stanley is even more bullish with a $70 target.

If Morgan Stanley is right, WiseTech shares could more than double from here.

At $34.76, I think the market has already priced in plenty of bad news, while the upside could be significant if earnings keep growing.

The post Down 63%, I think WiseTech shares could be heading for a huge comeback appeared first on The Motley Fool Australia.

More reading

• 2 ASX growth shares tipped to return 20% to 77%
• By September 2027, $5,000 invested in WiseTech shares could turn into…
• Xero and Megaport: 2 ASX tech shares the market can’t agree on
• WiseTech shares are down 62%. Why are brokers still bullish?
• Down 62%, are WiseTech shares now a buy, hold or sell?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX shares have slumped this week as investors digest renewed conflict in the Middle East, oil prices and supply concerns, climbing inflation, and the potential for further interest rate hikes.

But here are five S&P/ASX 200 Index (ASX: XJO) shares that could turn the index around over the next 12 months. And they’re all rated a strong buy by brokers, with upsides of up to 62%.

Let’s take a look.

Life360 Inc (ASX: 360)

Life360 posted a strong second-quarter FY26 update in mid-August, including a 38% increase in revenue, and a 53% increase in adjusted EBITDA. And the company expects FY26 revenue growth to accelerate 33% to 40% year on year. But investors weren’t impressed, likely because they were expecting another upward revision to FY26 revenue guidance. But it looks like brokers now view the shares as below fair value. Market Index shows all brokers have a strong buy rating on the ASX shares and the $31.72 target price implies a potential 60% upside, at the time of writing.

Mesoblast Ltd (ASX: MSB)

The clinical-stage ASX biotech company has gained some attention since it posted its FY26 results last month. The company, which develops and commercialises allogeneic cellular medicines to treat complex diseases, posted a sharp increase in revenue to US$120.3 million for FY26, and a 44% reduction in net loss. And there’s plenty of potential for more growth ahead. Its products, particularly Ryoncil, are gaining traction and the business is well-funded. Brokers are also bullish that sales can continue growing strongly in FY27. Market Index data shows all brokers have a strong buy rating for the ASX shares. The $3.60 target price implies a potential 62% upside, at the time of writing. 

Megaport Ltd (ASX: MP1)

The ASX tech shares flew higher in late-May but slumped around 20% in August after the company posted its FY26 results. Megaport reported a 37% increase in full-year revenue, and EBITDA was up 24%. But, on the bottom line, its statutory net loss climbed to $39 million, up from $300,000 in FY25. Investors weren’t impressed and many quickly sold up their shares, sending the share price tumbling. But the company is continuing to grow and it has confirmed several new contracts since late-April. Brokers are bullish that we’ll see a share price correction ahead. Market Index data show that all brokers have a strong buy rating for Megaport shares. The $24.80 average target price implies a potential 39% upside, at the time of writing.

Nick Scali Ltd (ASX: NCK)

Shares of household furniture importer and retailer Nick Scali have plunged in 2026 as high interest rates and cost-of-living pressures continue to delay shoppers from buying big-ticket discretionary items like furniture. But the company’s latest FY26 results announcement shows the business is still operating well with a strong gross margin improvement. Last month, Nick Scali announced a 4% increase in revenue and a 22% increase in NPAT. Many experts still view Nick Scali as a high quality retailer with growth potential ahead. Market Index data shows the majority have a strong buy rating on the ASX shares. The $18.50 average target price implies around a 28% upside ahead, at the time of writing.

Judo Capital Holdings Ltd (ASX: JDO)

Judo was one of the strongest-performing bank shares on the ASX earlier this year. But the stock crashed 43% in late-June after it downgraded its profit guidance for FY26, and it has struggled to recover. Even a stronger-than-expected FY26 result wasn’t enough to reignite investor confidence. Judo’s NPAT increased 29% and profit before tax increased 34%, the top end of Judo’s revised guidance range. It’s clear that the sell-off was way overdone and that the bank’s latest results show it is growing stronger than many anticipated. Market Index data shows the majority of brokers have a strong buy rating on the shares. The $1.51 average target price implies a potential upside of around 50%, at the time of writing.

The post Brokers rate these 5 ASX shares as a strong buy, and tip upsides of 28% to 62% appeared first on The Motley Fool Australia.

More reading

• 7 ASX healthcare stock picks from Bell Potter
• 2 top ASX 200 shares tipped to return 23% to 45%
• Here are the top 10 ASX 200 shares today
• Xero and Megaport: 2 ASX tech shares the market can’t agree on
• 3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Megaport. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Nick Scali. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Corporate Travel Management Ltd (ASX: CTD) shares have delivered one of the ASX’s most eye-catching returns — for all the wrong reasons.

The stock only returned to the ASX last Thursday after more than a year suspended from trading. Investors wasted little time selling, sending Corporate Travel shares crashing 86% on their first day back to close at $2.32.

After briefly stabilising, the selling resumed on Wednesday. The shares fell another 9% to $2.03 during afternoon trading.

And shareholders have another headache to contend with.

Potential class action adds to investor concerns

Law firm Phi Finney McDonald is investigating a potential class action against Corporate Travel Management and its former auditor, PwC Australia.

According to the law firm’s website, the investigation concerns alleged financial misreporting over several years. The potential class action would allege Corporate Travel misled investors in its annual financial reports between 2020 and 2024, potentially contravening its continuous disclosure obligations under the Corporations Act.

PwC Australia is also alleged to have engaged in misleading or deceptive conduct and made false statements regarding its auditing of Corporate Travel’s financial reports in accordance with applicable standards.

The proposed action would allege that this conduct caused Corporate Travel shares to trade at an inflated price, resulting in losses for investors who bought shares during the relevant period.

Roop Sandhu, Principal Lawyer at Phi Finney McDonald, notes:

Investors have a right to expect that financial statements from their listed investments are a true and fair reflection of the company’s performance. They are rightfully concerned about their investments in Corporate Travel due to its long term suspension. Likewise, investors have a right to assume that an auditor’s standards meet the relevant legislation and regulatory requirements.

No class action has been filed at this stage. Nevertheless, it’s another issue shareholders could probably have done without.

Some signs of progress

Corporate Travel shares were suspended in August 2025 after accounting problems emerged around customer charge rates in its UK operations.

Since then, the company has been working through a significant customer remediation program. Corporate Travel has agreed or is close to finalising around 78% of refunds, leaving roughly $55 million still to resolve.

There are, however, some encouraging signs in the underlying business.

Corporate Travel’s FY26 result showed revenue and other income increasing 4% to $669.9 million. Underlying EBITDA jumped 36% to $113.6 million.

The company also returned to profitability, reporting net profit after tax (NPAT) of $17.7 million, compared with a $348.5 million loss a year earlier.

Foolish takeaway

Corporate Travel’s underlying business appears to be making progress. However, investors are being asked to look beyond an extraordinary amount of uncertainty.

The remediation program still has work to do, while the potential class action adds another layer of risk. Most importantly, the return of Corporate Travel shares to trading has demonstrated just how quickly investor confidence can evaporate when a company’s financial reporting comes under scrutiny.

For prospective investors, the question may not simply be whether Corporate Travel shares look cheap after their spectacular collapse. It’s whether the market has enough information yet to confidently say the worst is over.

The post Corporate Travel shares plunge another 9%: Is the worst yet to come? appeared first on The Motley Fool Australia.

More reading

• Where does it end? Corporate Travel hit with another blow after crashing 85%
• 3 ASX shares that cut their dividend this reporting season
• Corporate Travel Management shares crashed 80% on their first day back. What happened?
• Why I’m still smiling after losing 85%
• Warning: Corporate Travel shares have crashed 80%. What on earth just happened?

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Corporate Travel Management. The Motley Fool Australia has positions in and has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.